Prognostic and Predictive Role of the VeriStrat Plasma Test in Patients with Advanced Non–Small-Cell Lung Cancer Treated with Erlotinib or Placebo in the NCIC Clinical Trials Group BR.21 Trial-Reference-Cited by-同舟云学术

Prognostic and Predictive Role of the VeriStrat Plasma Test in Patients with Advanced Non–Small-Cell Lung Cancer Treated with Erlotinib or Placebo in the NCIC Clinical Trials Group BR.21 Trial

Published:2012-11 Issue:11 Volume:7 Page:1653-1660
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Carbone David P.,Ding Keyue,Roder Heinrich,Grigorieva Julia,Roder Joanna,Tsao Ming-Sound,Seymour Lesley,Shepherd Frances A.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference27 articles.

1. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N Engl J Med,2005

2. Erlotinib in lung cancer - molecular and clinical predictors of outcome;Tsao;N Engl J Med,2005

3. National Cancer Institute of Canada Clinical Trials Group Study BR.21. Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21;Zhu;J Clin Oncol,2008

4. Plasma transforming growth factor alpha and amphiregulin protein levels in NCIC Clinical Trials Group BR.21;Addison;J Clin Oncol,2010

5. Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study;Taguchi;J Natl Cancer Inst,2007

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on trends in development and translation of omics signatures in cancer;Computational and Structural Biotechnology Journal;2024-12

2. Molecular and translational biology of the blood-based VeriStrat® proteomic test used in cancer immunotherapy treatment guidance;Journal of Mass Spectrometry and Advances in the Clinical Lab;2023-11

3. Prospective on Imaging Mass Spectrometry in Clinical Diagnostics;Molecular & Cellular Proteomics;2023-09

4. The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer;International Journal of Molecular Sciences;2023-03-02

5. Molecular & Translational Biology of the Blood-Based VeriStrat® Proteomic Test Used in Cancer Immunotherapy Treatment Guidance;2022-12-30